Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Allogeneic UCB Therapy With EPO in Children With CP

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2013 by Bundang CHA Hospital.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
Ministry of Health & Welfare, Korea
LG Life Sciences
Chong Kun Dang Pharmaceutical
CHA University
Information provided by (Responsible Party):
MinYoung Kim, M.D., Bundang CHA Hospital
ClinicalTrials.gov Identifier:
NCT01991145
First received: November 17, 2013
Last updated: NA
Last verified: November 2013
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)